UK markets closed

Vistin Pharma ASA (VISTN.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
23.30-0.10 (-0.43%)
At close: 04:25PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
438,335
435,391
287,675
275,812
253,159
Cost of revenue
232,133
233,150
199,876
143,935
110,216
Gross profit
206,202
202,241
87,799
131,877
142,943
Operating expenses
Selling general and administrative
-
26,099
19,820
17,403
16,012
Total operating expenses
131,787
133,644
93,895
98,627
97,387
Operating income or loss
74,415
68,597
-6,096
33,250
45,556
Interest expense
175,124
2,266
2,140
357
820
Income before tax
72,155
58,518
-6,008
31,995
-124,272
Income tax expense
15,923
12,923
-1,293
7,129
-27,317
Income from continuing operations
56,231
45,595
-4,715
24,866
-96,955
Net income
56,232
45,596
-4,716
24,867
-96,955
Net income available to common shareholders
56,232
45,596
-4,716
24,867
-96,955
Basic EPS
1.00
1.03
-0.11
0.56
-2.19
Diluted EPS
1.00
1.03
-0.11
0.56
-2.19
Basic average shares
44,345
44,345
44,345
44,345
44,345
Diluted average shares
44,345
44,345
44,345
44,345
44,345